Representative before the EPO

Research organisation logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 26 EP applications Nicolas Favre has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 2, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11712218

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TUMOR INITIATING CELLS

IPC classification:
A61K 31/65, A61K 38/00, A61K 39/00, A61P 35/00
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11714985

MODULATING XRN1

IPC classification:
C12N 15/113
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12714337

CULTURE MEDIUM SUITABLE FOR THE CULTURE OF UNDIFFERENTIATED CELLS

IPC classification:
C12N 5/00, C12N 5/071
Applicant:
Novartis Forschungsstiftung
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION WITHDRAWN
EP12725781

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TRIPLE-NEGATIVE BREAST CANCER

IPC classification:
A61K 39/395, A61K 48/00, A61P 35/00, C07K 16/30
Applicant:
Friedrich Miescher Institute For Biomedical Research
Applicant:
Novartis Forschungsstiftung
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP12791128

ROD CELL-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, C07K 14/475, C12N 5/10, C12N 15/79
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12781128

EARLY DIAGNOSTIC OF NEURODEGENERATIVE DISEASES

IPC classification:
G01N 33/68
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP12781127

NEW TREATMENT FOR NEURODEGENERATIVE DISEASES

IPC classification:
A61K 31/357, A61K 31/4178, A61K 31/517, A61K 31/713, A61K 39/395, A61P 25/02, A61P 25/28, G01N 33/68
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP12824808

CDCP1 AND BREAST CANCER

IPC classification:
A61K 31/70, A61K 31/7088, A61K 39/39, A61K 39/395, A61P 35/00
Applicant:
Friedrich Miescher Institute For Biomedical Research
Applicant:
Novartis AG
Applicant:
Novartis Forschungsstiftung
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION WITHDRAWN
EP13712296

INHIBITION OF INTERLEUKIN- 8 AND/OR ITS RECEPTOR CXCRL IN THE TREATMENT HER2/HER3 -OVEREXPRESSING BREAST CANCER

IPC classification:
C07K 16/24, C07K 16/28
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP11754420

PHOSPHORYLATED TWIST1 AND METASTASIS

IPC classification:
A61K 38/17, A61P 35/04, C07K 16/18
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
APPLICATION WITHDRAWN
EP13732495

TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP13734067

NEW TREATMENT FOR NEURODEGENERATIVE DISEASES

IPC classification:
A61K 38/50, A61K 39/00, A61K 48/00, C12N 9/80
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP13756391

RETINAL OFF CIRCUIT-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, A61P 27/02, C12N 5/079, C12N 15/85, C12N 15/86
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP11725716

TREATING CANCER BY MODULATING MAMMALIAN STERILE 20-LIKE KINASE 3

IPC classification:
A61P 35/00, C07K 16/00, C07K 16/30
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Status:
APPLICATION WITHDRAWN
EP14706119

NOVEL METHODS FOR THE TARGETED INTRODUCTION OF VIRUSES INTO CELLS

IPC classification:
C12N 7/00, C12N 15/87
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP14715425

METHOD FOR THE GENERATION OF POLYCYSTRONIC VECTORS

IPC classification:
C12N 15/64, C12N 15/66
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP14736451

ELECTRICALLY CONDUCTIVE SAMPLE BLOCKS FOR SCANNING ELECTRON MICROSCOPY

IPC classification:
G01N 1/00, G01N 1/36, H01J 37/00, H01J 37/20
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
GRANT OF PATENT INTENDED
EP14732978

RETINAL ON BIPOLAR CELLS-SPECIFIC ARTIFICIAL PROMOTER

IPC classification:
A61K 48/00, C12N 15/85, C12N 15/861
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP11781557

ANTI-FUNGAL AGENTS

IPC classification:
C07K 14/37, C12N 15/80, C12N 15/81
Applicant:
ETH Transfer
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Novartis Pharma AG
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14780581

NEW SCREENING METHOD FOR THE TREATMENT FRIEDREICH'S ATAXIA

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Friedrich Miescher Institute For Biomedical Research
Applicant:
Novartis AG
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION IN PROGRESS
EP15709745

MÜLLER CELL-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, C12N 15/85
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15709743

AII RETINAL AMACRINE CELL-SPECIFIC PROMOTER

IPC classification:
A61K 48/00, C12N 15/85
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15714022

PREDICTION OF PREECLAMPSIA USING MICRORNA

IPC classification:
C12Q 1/68
Applicant:
University Hospital Basel (Universitätsspital Basel)
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15734461

New treatment against influenza virus

IPC classification:
A61K 31/00, A61K 31/713, A61K 39/395, A61P 31/16
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15750455

COMBINATION OF A BRAFV600E INHIBITOR AND MERTK INHIBITOR TO TREAT MELANOMA

IPC classification:
A61K 31/437, A61K 31/4706, A61K 31/506, A61P 35/00
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
EXAMINATION REQUESTED
EP15778746

LATS AND BREAST CANCER

IPC classification:
A61K 31/138, A61K 39/395, A61K 48/00, A61P 35/00, C12N 15/113
Applicant:
Friedrich Miescher Institute For Biomedical Research
Agent:
Nicolas Favre, Friedrich Miescher Institute For Biomedical Research
Status:
Request for examination was made

Please Sign in to use this feature